A new challenge for the Mexican health system:

hepatitis C in people who inject drugs 

Autores: Magis Rodríguez Carlos, Marín Navarrete Rodrigo, García Juárez Ignacio

Resumen

Injecting-drug use is present in 179 of 206 countries worldwide, with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) prevalence of 17.8% and 52.3%, respectively, among the 15.6 million people who inject drugs (PWIDs) (Degenhardt et al., 2017; Platt et al., 2016). This epidemic produces a high impact on global public health by increasing days lost associated to disability, morbidity, and mortality (Degenhardt et al., 2017).

Palabras clave: .

2020-03-26   |   141 visitas   |   Evalua este artículo 0 valoraciones

Vol. 42 Núm.4. Julio-Agosto 2019 Pags. 147-8 Salud Ment 2019; 42(4)